CRN Welcomes FDA Focus on Strengthening GRAS Transparency, Calls for National Uniformity
AUGUST 11, 2026 — CRN welcomes the Food and Drug Administration’s focus on strengthening the Generally Recognized as Safe (GRAS) framework, through its proposed rule announced yesterday by the U.S. Department of Health and Human Services (HHS) and FDA. CRN supports science-based policies that strengthen consumer confidence and food safety while preserving access to safe, innovative nutritional products.
